Cargando…

Cognitive function among women with breast cancer receiving endocrine therapy: what are the impacts?

Detalles Bibliográficos
Autores principales:	Fardell, Joanna E, Walker, Adam, Chan, Raymond J, Vardy, Janette L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121332/ https://www.ncbi.nlm.nih.gov/pubmed/36964714 http://dx.doi.org/10.1093/jncics/pkad026

Ejemplares similares

Sustained Mild Inflammation in Cancer Survivors: Where to from Here?
por: Walker, Adam K, et al.
Publicado: (2022)

Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review
por: Haggstrom, Lucy R., et al.
Publicado: (2022)

Screening for cognitive symptoms among cancer patients during chemotherapy: Sensitivity and specificity of a single item self‐report cognitive change score
por: Fardell, Joanna E., et al.
Publicado: (2022)

Understanding the impact of breast cancer adjuvant endocrine therapy on cognitive function: a work in progress
por: Ganz, Patricia A
Publicado: (2016)

Symptom Clusters in Survivorship and Their Impact on Ability to Work among Cancer Survivors
por: Fardell, Joanna E., et al.
Publicado: (2023)

Anxiety, depression, and concentration in cancer survivors: National Health and Nutrition Examination Survey results
por: Fardell, Joanna E., et al.
Publicado: (2023)

Low dose aspirin blocks breast cancer-induced cognitive impairment in mice
por: Walker, Adam K., et al.
Publicado: (2018)

“POLAR-izing” Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy
por: Teng, Christina, et al.
Publicado: (2022)

The Impact of Endocrine Disruptors on Endocrine Targets
por: Gregoraszczuk, Ewa L., et al.
Publicado: (2013)

Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy
por: Lo, Joan C., et al.
Publicado: (2021)

Review of bone health in women with estrogen receptor–positive breast cancer receiving endocrine therapy
por: Malagrinò, Matteo, et al.
Publicado: (2023)

Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer
por: Vardy, Janette, et al.
Publicado: (2013)

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

Endocrine Toxicities of Antineoplastic Therapy
por: Puliani, Giulia, et al.
Publicado: (2021)

Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
por: Van Poznak, Catherine
Publicado: (2010)

Primary Endocrine Therapy in Older Women with Breast Cancer
por: Pepping, R. M. C., et al.
Publicado: (2017)

Association of Endocrine Therapy and Dementia in Women with Breast Cancer
por: Thompson, Mikayla R, et al.
Publicado: (2021)

Predictive markers of endocrine response in breast cancer
por: Mosly, Duniya, et al.
Publicado: (2018)

Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer.
por: Stuart-Harris, R., et al.
Publicado: (1985)

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
por: Sestak, Ivana, et al.
Publicado: (2019)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

Endocrine therapy: defining the path of least resistance
por: Stone, Andrew, et al.
Publicado: (2014)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
por: Malek, Alexandre E, et al.
Publicado: (2021)

What’s wrong with early diagnosis of breast cancer in young women?
por: Codacci-Pisanelli, Giovanni
Publicado: (2013)

Association between genetic polymorphisms in cytochrome P450 enzymes and survivals in women with breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis
por: Chan, Carmen Wing Han, et al.
Publicado: (2022)

Applying a Women's Health Lens to Endocrine and Metabolic Disorders
por: Sriram, Usha
Publicado: (2021)

Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study
por: van Hellemond, Irene E.G., et al.
Publicado: (2019)

Breast density predicts endocrine treatment outcome in the adjuvant setting
por: Cuzick, Jack
Publicado: (2012)

Diagnostics and Therapeutics in Early Stage Breast Cancer Receiving Neoadjuvant Systemic Therapy
por: Belli, Paolo, et al.
Publicado: (2023)

An unmet need: tailoring extended adjuvant endocrine therapy
por: Bianchini, G, et al.
Publicado: (2013)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
por: Lambertini, Matteo, et al.
Publicado: (2018)

Defects in mismatch repair: the Achilles heel of estrogen receptor positive breast cancer with intrinsic endocrine therapy resistance?
por: Haricharan, Svasti, et al.
Publicado: (2017)

Early breast cancer in elderly women: surgery or primary endocrine therapy?
por: Rocco, N, et al.
Publicado: (2010)

Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?
por: Duric, V M, et al.
Publicado: (2005)

New Perspectives on Diagnostics, Prognosis, and Therapy in Aggressive Endocrine Tumours
por: Appetecchia, Marialuisa, et al.
Publicado: (2012)

You Get What You Pay For: Breast MRI Screening of Women With Dense Breasts Is Cost-effective
por: Kuhl, Christiane K, et al.
Publicado: (2021)

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Chemobrain Experienced by Breast Cancer Survivors: A Meta-Ethnography Study Investigating Research and Care Implications
por: Selamat, Maryam Hafsah, et al.
Publicado: (2014)

Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction?
por: McCartney, Amelia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qh7evbh9rrpvb3kocl6i1cr2eb